143 related articles for article (PubMed ID: 36558184)
1. Evaluation of In Vitro Cytotoxic Potential of Avarol towards Human Cancer Cell Lines and In Vivo Antitumor Activity in Solid Tumor Models.
Stanojkovic TP; Filimonova M; Grozdanic N; Petovic S; Shitova A; Soldatova O; Filimonov A; Vladic J; Shegay P; Kaprin A; Ivanov S; Nikitovic M
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558184
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of cytotoxic and mutagenic activity of avarol.
Pejin B; Iodice C; Kojic V; Jakimov D; Lazovic M; Tommonaro G
Nat Prod Res; 2016 Jun; 30(11):1293-6. PubMed ID: 26181496
[TBL] [Abstract][Full Text] [Related]
3. Isolation of sesquiterpenoids from sponge Dysidea avara and chemical modification of avarol as potential antitumor agents.
Shen YC; Lu CH; Chakraborty R; Kuo YH
Nat Prod Res; 2003 Apr; 17(2):83-9. PubMed ID: 12713119
[TBL] [Abstract][Full Text] [Related]
4. Further in vitro biological activity evaluation of amino-, thio- and ester-derivatives of avarol.
Tommonaro G; Pejin B; Iodice C; Tafuto A; De Rosa S
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):684-6. PubMed ID: 26114310
[TBL] [Abstract][Full Text] [Related]
5. Further in vitro biological activity evaluation of amino-, thio- and ester-derivatives of avarol.
Tommonaro G; Pejin B; Iodice C; Tafuto A; De Rosa S
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):333-5. PubMed ID: 24939096
[TBL] [Abstract][Full Text] [Related]
6. Avarol, a cytostatically active compound from the marine sponge Dysidea avara.
Müller WE; Zahn RK; Gasić MJ; Dogović N; Maidhof A; Becker C; Diehl-Seifert B; Eich E
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 80(1):47-52. PubMed ID: 2858349
[TBL] [Abstract][Full Text] [Related]
7. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease.
Tommonaro G; García-Font N; Vitale RM; Pejin B; Iodice C; Cañadas S; Marco-Contelles J; Oset-Gasque MJ
Eur J Med Chem; 2016 Oct; 122():326-338. PubMed ID: 27376495
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mitosis by avarol, a natural product isolated from the sponge Dysidea avara.
Müller WE; Dogovic N; Zahn RK; Maidhof A; Diehl-Seifert B; Becker C; Sachsse W; Gasic MJ; Schröder HC
Basic Appl Histochem; 1985; 29(4):321-30. PubMed ID: 4096684
[TBL] [Abstract][Full Text] [Related]
9. A new bioactive derivative of avarol from the marine sponge Dysidea avara.
Crispino A; de Giulio A; de Rosa S; Strazzullo G
J Nat Prod; 1989; 52(3):646-8. PubMed ID: 2778453
[TBL] [Abstract][Full Text] [Related]
10. Avarol induces apoptosis in pancreatic ductal adenocarcinoma cells by activating PERK-eIF2α-CHOP signaling.
Namba T; Kodama R
Mar Drugs; 2015 Apr; 13(4):2376-89. PubMed ID: 25894488
[TBL] [Abstract][Full Text] [Related]
11. In vitro avarol does affect the growth of Candida sp.
Pejin B; Ciric A; Markovic D; Tommonaro G; Sokovic M
Nat Prod Res; 2016 Sep; 30(17):1956-60. PubMed ID: 26405848
[TBL] [Abstract][Full Text] [Related]
12. The redox couple avarol/avarone in the fight with malignant gliomas: the case study of U-251 MG cells.
Pejin B; Tommonaro G; Glumac M; Jakimov D; Kojic V
Nat Prod Res; 2018 Mar; 32(5):616-620. PubMed ID: 28504009
[TBL] [Abstract][Full Text] [Related]
13. Developmental aberrations in sea-urchin eggs induced by avarol and two cogeners, the main sesquiterpenoid hydroquinones from the marine sponge, Dysidea avara.
Cariello L; De Nicola Giudici M; Zanetti L
Comp Biochem Physiol C Comp Pharmacol; 1980; 65C(1):37-41. PubMed ID: 6102012
[No Abstract] [Full Text] [Related]
14. Sponge secondary metabolites: biochemical and ultrastructural localization of the antimitotic agent avarol in Dysidea avara.
Müller WE; Diehl-Seifert B; Sobel C; Bechtold A; Kljajić Z; Dorn A
J Histochem Cytochem; 1986 Dec; 34(12):1687-90. PubMed ID: 3782777
[TBL] [Abstract][Full Text] [Related]
15. A new bioactive sesquiterpenoid quinone from the Mediterranean Sea marine sponge Dysidea avara.
Hamed AN; Wätjen W; Schmitz R; Chovolou Y; Edrada-Ebel R; Youssef DT; Kamel MS; Proksch P
Nat Prod Commun; 2013 Mar; 8(3):289-92. PubMed ID: 23678793
[TBL] [Abstract][Full Text] [Related]
16. Further in vitro evaluation of cytotoxicity of the marine natural product derivative 4'-leucine-avarone.
Pejin B; Iodice C; Tommonaro G; Bogdanovic G; Kojic V; De Rosa S
Nat Prod Res; 2014; 28(5):347-50. PubMed ID: 24422776
[TBL] [Abstract][Full Text] [Related]
17. Application of cell culture for the production of bioactive compounds from sponges: synthesis of avarol by primmorphs from Dysidea avara.
Müller WE; Böhm M; Batel R; De Rosa S; Tommonaro G; Müller IM; Schröder HC
J Nat Prod; 2000 Aug; 63(8):1077-81. PubMed ID: 10978201
[TBL] [Abstract][Full Text] [Related]
18. Liposomal integration method for assessing antioxidative activity of water insoluble compounds towards biologically relevant free radicals: example of avarol.
Nakarada Đ; Pejin B; Tommonaro G; Mojović M
J Liposome Res; 2020 Sep; 30(3):218-226. PubMed ID: 31146614
[TBL] [Abstract][Full Text] [Related]
19. Identification of avarol derivatives as potential antipsoriatic drugs using an in vitro model for keratinocyte growth and differentiation.
Amigó M; Schalkwijk J; Olthuis D; De Rosa S; Payá M; Terencio MC; Lamme E
Life Sci; 2006 Nov; 79(25):2395-404. PubMed ID: 16973179
[TBL] [Abstract][Full Text] [Related]
20. Avarol inhibits TNF-alpha generation and NF-kappaB activation in human cells and in animal models.
Amigó M; Payá M; Braza-Boïls A; De Rosa S; Terencio MC
Life Sci; 2008 Jan; 82(5-6):256-64. PubMed ID: 18177902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
